Neuralink Begins Recruiting Paralyzed Patients for First Human Trials of Brain Implant Despite Controversy Over Animal Deaths

Neuralink received FDA approval and opened recruitment for first human trials of its brain implant device to help paralyzed patients control computers.
The trials aim to evaluate safety and functionality of Neuralink's robotic surgical implant procedure and wireless brain-computer interface.
Goals include enabling paralyzed patients to control cursors or keyboards with thoughts and eventually restoring full body movement.
Neuralink faced allegations of animal mistreatment leading to painful deaths during testing.
Musk claims the device could also improve human-AI communication and address existential threats posed by artificial intelligence.